Retatrutide — Peptide Glossary | RetatrutideCompare

An investigational triple agonist peptide (GLP-1/GIP/Glucagon) developed by Eli Lilly. Also known as LY3437943. Phase 2 clinical trials demonstrated exceptional metabolic effects. Available for research use only.
Category: Research Peptides & Compounds